Recognized by industry leaders for extensive coverage on African Asset Management
Mediterrania Capital Partners Co-Invests in Laprophan
This product is currently unavailable.
Description
381
Mediterrania Capital Partners through its fund MC IV, alongside Germany’s development finance institution DEG, Proparco and FMO, has acquired an undisclosed stake in Laprophan, one of the leading pharmaceutical companies in Morocco.
